Late Breaking Abstract - Explore the effective dose of bronchodilator nebulization via high flow nasal cannula in adult COPD and asthma patients
Conclusion: Bronchodilator delivery via HFNC is similarly effective as MDI with spacer. Standard label dose (2.5mg) of albuterol via HFNC is sufficient to cause bronchodilation for asthma and COPD patients.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Li, J., Hadeer, M., Zhao, M., Fink, J. Tags: Airway pharmacology and treatment Source Type: research
More News: Albuterol | Asthma | Chronic Obstructive Pulmonary | Drugs & Pharmacology | Proair HFA | Respiratory Medicine | Spirometry | Ventolin